0001104659-24-027567.txt : 20240226
0001104659-24-027567.hdr.sgml : 20240226
20240226170044
ACCESSION NUMBER: 0001104659-24-027567
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240222
FILED AS OF DATE: 20240226
DATE AS OF CHANGE: 20240226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DEC TIMOTHY C
CENTRAL INDEX KEY: 0001194020
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35518
FILM NUMBER: 24679947
MAIL ADDRESS:
STREET 1: C/O OPGEN, INC.
STREET 2: 708 QUINCE ORCHARD ROAD, SUITE 205
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001356576
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9715 KEY WEST AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-838-2500
MAIL ADDRESS:
STREET 1: 9715 KEY WEST AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060317
4
1
tm247055-3_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-02-22
0
0001356576
SUPERNUS PHARMACEUTICALS, INC.
SUPN
0001194020
DEC TIMOTHY C
C/O SUPERNUS PHARMACEUTICALS, INC.
9715 KEY WEST AVENUE
ROCKVILLE
MD
20850
0
1
0
0
Senior Vice-President & CFO
0
Common Stock
2024-02-22
4
A
0
500
0
A
6004
D
Restricted Stock Unit
2024-02-22
4
D
0
500
0
D
Common Stock
500
1000
D
Restricted Stock Unit
2024-02-22
4
A
0
12000
0
A
Common Stock
12000
12000
D
Employee Stock Option (Right to Buy)
27.94
2024-02-22
4
A
0
50000
0
A
2034-02-22
Common Stock
50000
50000
D
Includes an aggregate of 415 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan.
Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023.
These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025.
The option vests in four equal annual installments beginning on February 22, 2025.
/s/ Timothy C. Dec
2024-02-26